|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 139.57 USD | +1.59% |
|
-0.29% | +19.61% |
| 07:14pm | Wall Street banks rule on staff betting on prediction markets, sources say | RE |
| 07-09 | FTSE 100 held back by AstraZeneca trial setback | AN |
Company Valuation: Citigroup Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 119,830 | 87,604 | 98,450 | 133,126 | 208,789 | 238,047 | - | - |
| Change | - | -26.89% | 12.38% | 35.22% | 56.84% | 14.01% | - | - |
| Enterprise Value (EV) | 119,830 | 87,604 | 98,450 | 133,126 | 208,789 | 238,047 | 238,047 | 238,047 |
| Change | - | -26.89% | 12.38% | 35.22% | 56.84% | 14.01% | 0% | 0% |
| P/E | 5.96x | 6.46x | 12.7x | 11.9x | 16.7x | 12.8x | 11x | 9.66x |
| PBR | 0.65x | 0.48x | 0.52x | 0.69x | 1.06x | 1.19x | 1.11x | 1.03x |
| PEG | - | -0.2x | -0.3x | 0.3x | 0.9x | 0.2x | 0.7x | 0.7x |
| Capitalization / Revenue | 1.67x | 1.16x | 1.25x | 1.64x | 2.45x | 2.53x | 2.44x | 2.34x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 2.53x | 2.44x | 2.34x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 6.35x | 5.91x | 5.61x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | 2.04 | - | 2.08 | 2.18 | 2.32 | 2.512 | 2.733 | 3.077 |
| Rate of return | 3.38% | - | 4.04% | 3.1% | 1.99% | 1.8% | 1.96% | 2.2% |
| EPS 2 | 10.14 | 7 | 4.04 | 5.94 | 6.99 | 10.94 | 12.68 | 14.45 |
| Distribution rate | 20.1% | - | 51.5% | 36.7% | 33.2% | 23% | 21.6% | 21.3% |
| Net sales 1 | 71,884 | 75,338 | 78,462 | 81,139 | 85,225 | 94,203 | 97,741 | 101,932 |
| EBITDA | - | - | - | - | - | - | - | - |
| EBIT 1 | 23,691 | 24,046 | 22,096 | 27,155 | 30,093 | 37,475 | 40,309 | 42,461 |
| Net income 1 | 20,758 | 13,700 | 7,850 | 11,628 | 13,097 | 18,861 | 20,406 | 21,743 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 60.39 | 45.23 | 51.44 | 70.39 | 116.69 | 139.57 | 139.57 | 139.57 |
| Nbr of stocks (in thousands) | 1,984,267 | 1,936,853 | 1,913,882 | 1,891,265 | 1,789,266 | 1,705,577 | - | - |
| Announcement Date | 1/14/22 | 1/13/23 | 1/12/24 | 1/15/25 | 1/14/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 12.56x | - | - | 1.83% | 234B | ||
| 18.02x | 7.5x | - | 1.94% | 344B | ||
| 17.03x | 11.32x | - | 1.81% | 316B | ||
| 17.22x | - | - | 1.26% | 177B | ||
| 11.23x | 1.08x | - | 3.09% | 59.38B | ||
| 16.78x | 5.3x | - | 3.29% | 29.67B | ||
| 7.53x | - | - | 3.86% | 28.44B | ||
| 11.54x | 8.47x | - | 3.6% | 27.73B | ||
| 9.7x | 7.19x | - | 3.22% | 24.88B | ||
| 12.53x | 11.74x | - | 2.96% | 24.91B | ||
| Average | 13.41x | 7.51x | 2.69% | 126.59B | ||
| Weighted average by Cap. | 15.65x | 8.57x | 2% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- C Stock
- Valuation Citigroup Inc.
Select your edition
All financial news and data tailored to specific country editions
















